FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to oncology and deals with application of antimicrobial protein of human platelets as anti-tumour medication.
EFFECT: invention insures extension of arsenal of anti-tumour medications for treatment of malignant neoplasms.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SELECTION OF MICROORGANISMS POSSESSING ENHANCED RESISTANCE TO CATIONIC ANTIBACTERIAL PEPTIDES AND SERUM BLOOD | 2006 |
|
RU2315112C1 |
METHOD FOR INCREASING OF POULTRY PRODUCTIVITY | 2004 |
|
RU2275804C2 |
METHOD OF PURULENT CHOLANGITIS TREATMENT | 2008 |
|
RU2404825C2 |
METHOD FOR MICROORGANISM SAMPLING AS COMPONENT OF PROBIOTIC PREPARATIONS | 2005 |
|
RU2293118C2 |
AGENT FOR INCREASING EFFICACY AND REDUCING TOXICITY OF ANTINEOPLASTIC PREPARATIONS | 2009 |
|
RU2410095C2 |
BIOACTIVE COMPLEX "ARCTIC+" AND METHOD OF TREATMENT OF ONCOLOGY DISEASES | 2006 |
|
RU2324489C2 |
AGENT FOR CORRECTING CYTOTOXIC EFFECTS OF PARANEOPLASTIC PROCESSES AND CHEMOTHERAPY SHOWING ANTICANCER ACTIVITY | 2011 |
|
RU2447888C1 |
ANTITUMOUR AGENT BASED ON BIODEGRADABLE NANOPARTICLES CARRYING A RECOMBINANT HUMAN TUMOR NECROSIS FACTOR ALPHA | 2018 |
|
RU2691938C1 |
HIGHLY EFFECTIVE METHOD FOR PREPARING DOSAGE FORM OF TARGETED ACTION FOR THERAPY OF MALIGNANT GROWTHS | 2019 |
|
RU2727924C1 |
MEDICATION INCREASING ANTITUMOUR EFFECT OF METHOTREXATE | 2009 |
|
RU2411947C1 |
Authors
Dates
2011-05-27—Published
2009-11-27—Filed